Related Experiment Videos
Hepatitis following thiopentone. A case report
British Journal of Anaesthesia
|August 1, 1979
Summary
Thiopentone, not halothane, likely caused jaundice and fever after repeated anesthesia. This highlights the importance of considering thiopentone when evaluating liver issues post-anesthesia.
Area of Science:
- Anesthesiology
- Hepatology
- Clinical Toxicology
Background:
- Repeated anesthesia administration poses risks for adverse drug reactions.
- Distinguishing causative agents in post-anesthetic complications is crucial for patient safety.
Observation:
- A patient presented with pyrexia (fever) and jaundice following multiple anesthetic procedures.
- The patient had received both thiopentone and halothane during their treatments.
Findings:
- Evidence strongly suggests thiopentone was the primary agent responsible for the patient's pyrexia and jaundice.
- Halothane was initially suspected, but further analysis pointed towards thiopentone as the causative factor.
Implications:
- Clinicians should exercise caution when attributing jaundice and hepatitis solely to halothane in patients with a history of thiopentone exposure.
- This case underscores the need for thorough patient history and differential diagnosis in managing post-anesthetic liver dysfunction.
- Awareness of thiopentone's potential hepatotoxicity is vital for anesthesiologists and hepatologists.